NovaBay Establishes Primary Proof of Concept for NVC-422 Phase 2 UCBE Clinical Program – Yahoo Finance

November 30, 2011 Posted By: Leave a comment
Nov. 30, 2011 (GLOBE NEWSWIRE) -- NovaBay (R) Pharmaceuticals, Inc. (NYSE AMEX:NBY), a clinical-stage biotechnology company developing ... forward-looking statement except as required by law.
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>